$MRVI News

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript

Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $5.5

Maravai LifeSciences (NASDAQ:MRVI) Surges After Crushing Q1 Estimates and Raising Full-Year Guidance

Maravai LifeSciences Holdings, Inc. 2026 Q1 - Results - Earnings Call Presentation

Maravai LifeSciences Raises FY2026 Sales Guidance from $200.000M-$210.000M to $205.000M-$215.000M vs $204.933M Est

Maravai LifeSciences Q1 Adj. EPS $0.01 Beats $(0.05) Estimate, Sales $65.837M Beat $53.046M Estimate

Maravai LifeSciences Holdings shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 sales guidance with its midpoint above estimates.

Maravai LifeSciences Holdings shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 sales guidance with its midpoint above estimates.

Maravai LifeSciences Holdings, Inc. 2025 Q4 - Results - Earnings Call Presentation

Maravai Lifesciences (NASDAQ:MRVI) Returns to Positive Adjusted EBITDA and Issues 2026 Guidance

Maravai LifeSciences Holdings shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 sales guidance with its midpoint above estimates.

Insights into Maravai LifeSciences Q4 Earnings

Maravai LifeSciences Sees FY2026 Sales $200.000M-$210.000M vs $203.430M Est

Maravai LifeSciences Q4 Adj. EPS $(0.04) Beats $(0.07) Estimate, Sales $49.866M Beat $49.047M Estimate

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026

What to Know About a New $9 Million Bet on an Energy Distributor Stock

This Biopharma Stock Has Surged Nearly 100% and One Fund Just Locked in Gains With a $10 Million Exit

Why Analysts See Maravai’s Story Shifting After Target Cut And Washed Out Share Price Range

Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $4.5

Why Analysts See Opportunity and Risk as Maravai’s Story Evolves After Management Shakeup